info@synchemia.com | sales@synchemia.com 
9766925136 
Home
>
API Impurities
>
Nitroso
>
N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143524 |
| CAS No | NA |
| Mol.F. | C14H17N3O5 |
| Mol.Wt. | 307.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143525 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-N0143526 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-N0143527 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143528 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143529 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143530 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143532 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143533 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143534 |
| CAS No | NA |
| Mol.F. | C23H29N5O2 |
| Mol.Wt. | 407.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143535 |
| CAS No | NA |
| Mol.F. | C15H17ClN4O2 |
| Mol.Wt. | 320.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143536 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143537 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143538 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
